Melanoma Journal Articles for August 2017

BMJ Case Reports 2017; doi:10.1136/bcr-2017-221430

Symbiotic lymph node metastasis from breast cancer and melanoma

 


Molecular medicine Reports

Grb2-associated binder 2 expression and its roles in uveal melanoma invasion

Meiling Chen, Yuehua Li, Xiuning Sun, Baogang Zhang, Wei Li, Shuxiao Wang, Xuetao Zhu, Feng Li, Lihong Shi

 

Published online on: August 3, 2017

https://doi.org/10.3892/mmr.2017.7151


Oncology Letters

Mechanisms of CXCR7 induction in malignant melanoma development

Xiao?Jing Li, Pai Liu, Wei?Wei Tian, Zhi?Feng Li, Bao?Guo Liu, Jian?Fang Sun

 

Published online on: August 4, 2017     https://doi.org/10.3892/ol.2017.6720


Dove Press

NRAS-mutant melanoma: current challenges and future prospect

Authors Muñoz-Couselo E, Zamora Adelantado E, Ortiz C, Soberino García J, Perez-Garcia J

Received 28 March 2017

Accepted for publication 6 June 2017

Published 8 August 2017 Volume 2017:10 Pages 3941—3947

DOI https://doi.org/10.2147/OTT.S117121


Checkpoint inhibitors in melanoma and early phase development in solid tumors: what’s the future?

Paolo A. Ascierto and Grant A. McArthur

Journal of Translational Medicine201715:173

https://doi.org/10.1186/s12967-017-1278-5

 

Received: 12 July 2017

Accepted: 1 August 2017

Published: 8 August 2017


Cancer Therapy & Oncology

Complete Remission of Metastatic Melanoma with Nivolumab and Complete Remission of Hepatitis C with Ledipasvir

Ying Y Zhong1, Michael Kozminsky2 and Benjamin M Brady3*

Submission: August 03, 2017; Published: August 08, 2017


Clinical Cancer Research

Prospective Validation of Molecular Prognostic Markers in Cutaneous Melanoma: A Correlative Analysis of E1690

Mohammed Kashani-Sabet, Mehdi Nosrati, James Miller, Richard Sagebiel, Stanley Leong, Andrew Lesniak, Schuyler Tong, Sandra Lee and John M. Kirkwood

DOI: 10.1158/1078-0432.CCR-17-1317


BioRxiv

Novel pleiotropic risk loci for melanoma and nevus density implicate multiple biological pathways

David Duffy, Gu Zhu, Xin Li, Marianna Sanna, Mark Iles, Leonie C. Jacobs, David M. Evans, Seyhan Yazar, Jonathan Beesley, Matthew Law, Peter Kraft, Alessia Visconti, John C. Taylor, Fan Liu, Margaret J. Wright, Anjali K. Henders, Lisa Bowdler, Dan Glass, Arfan M. Ikram, Andre G. Uitterlinden, Pamela A. Madden, Andrew C. Heath, Elliot C. Nelson, Adele C. Green, Stephen Chanock, Jennifer H. Barrett, Matthew A. Brown, Nicholas K. Hayward, Stuart MacGregor, Richard A. Sturm, Alex W. Hewitt, Melanoma GWAS Consortium, Manfred Kayser, David J. Hunter, Julia A. Newton Bishop, Timothy D. Spector, Grant W. Montgomery, David A. Mackey, George Davey Smith, Tamar E. Nijsten, D. Timothy Bishop, Veronique Bataille, Mario Falchi, Jiali Han, Nicholas G. Martin

doi: https://doi.org/10.1101/173112


JOJ Opthalmology

Rare and Interesting Case of Eye Choriodal Melanoma Presenting as a Congestive Glaucoma in a 55 Years Male Patient

Gowhar Ahmad*

Department of ophthalmology, University of Jammu and Kashmir, India Submission: January 28, 2017; Published: August 07, 2017

DOI: 10.19080/JOJO.2017.02.555629


BMC Cancer

Prognostic significance of BRAF and NRAS mutations in melanoma: a German study from routine care

  • Markus V. Heppt,
  • Timo Siepmann,
  • Jutta Engel,
  • Gabriele Schubert-Fritschle,
  • Renate Eckel,
  • Laura Mirlach,
  • Thomas Kirchner,
  • Andreas Jung,
  • Anja Gesierich,
  • Thomas Ruzicka,
  • Michael J. Flaigand
  • Carola BerkingEmail author

Contributed equally

BMC Cancer201717:536

https://doi.org/10.1186/s12885-017-3529-5

 

Received: 26 September 2016

Accepted: 2 August 2017

Published: 10 August 2017


BioRxiv

A subgroup of mitochondrial extracellular vesicles discovered in human melanoma tissues are detectable in patient blood

Su Chul Jang, Rossella Crescitelli, Aleksander Cvjetkovic, Valerio Belgrano, Roger Olofsson Bagge, Johanna L. Hoog, Karin Sundfeldt, Takahiro Ochiya, Raghu Kalluri, Jan Lotvall

doi: https://doi.org/10.1101/174193


NATURE REVIEWS CANCER | RESEARCH HIGHLIGHT

THERAPEUTIC RESISTANCE 

Ironing it out

Ulrike Harjes 

Nature Reviews Cancer (2017)

doi:10.1038/nrc.2017.71

Published online 11 August 2017


NATURE REVIEWS DRUG DISCOVERY | RESEARCH HIGHLIGHT 

CANCER IMMUNOTHERAPY

Searching in the immune checkpoint black box

  1. Teresa Villanueva 

Nature Reviews Drug Discovery (2017)

doi:10.1038/nrd.2017.163

Published online 11 August 2017


Journal of Clinical Pathology

Financial implications of Idylla testing in colorectal cancer, lung cancer and melanoma: a French laboratory point of view

Glen Le Flahec, Briac Guibourg, Pascale Marcorelles, Arnaud Uguen

http://dx.doi.org/10.1136/jclinpath-2017-204579


Journal of Neuro-Oncology

Metastatic melanoma: prognostic factors and survival in patients with brain metastases

  1. Frinton, D. Tong, J. Tan, G. Read, V. Kumar, S. Kennedy, C. Lim, R. E. Board

Clinical Study

First Online: 17 August 2017


Opthalmology

Uveal Melanoma Nuclear BRCA1-Associated Protein-1 Immunoreactivity Is an Indicator of Metastasis

Eszter Szalai, MD, PhD, Jill R. Wells, MD, Laura Ward, MSPH, Hans E. Grossniklaus, MD

Manuscript no. 2017-988.

DOI: http://dx.doi.org/10.1016/j.ophtha.2017.07.018


Int. J. Mol. Sci. 201718(8), 1809; doi:10.3390/ijms18081809

Protocatechuic Acid from Pear Inhibits Melanogenesis in Melanoma Cells

Xuan T. Truong, Seo-Hee Park, Yu-Geon Lee, Hang Yeon Jeong, Jae-Hak Moon 

 And Tae-Il Jeon

Received: 5 July 2017 / Revised: 13 August 2017 / Accepted: 17 August 2017 / Published: 21 August 2017


Dove Press

Investigation into the quantitative and qualitative characteristics of choroidal melanoma through magnetic resonance imaging and B-scan ultrasound

Authors Papayiannis V, Tsaousis KT, Kouskouras CA, Haritanti A, Diakonis VF, Tsinopoulos IT

Received 12 December 2016

Accepted for publication 11 April 2017

Published 22 August 2017 Volume 2017:11 Pages 1557—1564

DOI https://doi.org/10.2147/OPTH.S130009


Dove Press

Checkpoint inhibitors for malignant melanoma: a systematic review and meta-analysis

Authors Karlsson AK, Saleh SN

Received 28 August 2016

Accepted for publication 13 January 2017

Published 24 August 2017 Volume 2017:10 Pages 325—339

DOI https://doi.org/10.2147/CCID.S120877


American Journal of Epidemiology

RE: “INDOOR TANNING AND MELANOMA RISK: LONG-TERM EVIDENCE FROM A PROSPECTIVE POPULATION-BASED COHORT STUDY”

Jonathan E. Mayer

American Journal of Epidemiologyhttps://doi.org/10.1093/aje/kwx283

Published: 22 August 2017


ZNF23 Suppresses Cutaneous Melanoma Cell Malignancy via Mitochondria-Dependent Pathway

Zhang X.a · Ding C.b · Tian H.c · Dong X.d · Meng X.a · Zhu W.a · Liu B.a · Wang L.a · Huang M.a · Li C.

Cell Physiol Biochem 2017;43:147–157

https://doi.org/10.1159/000480333


Cancer Discovery

The 1q42.1 Risk Allele Promotes Melanoma via PARP1 Upregulation

DOI: 10.1158/2159-8290.CD-RW2017-152

Published OnlineFirst August 14, 2017


International Journal of Molecular Sciences

Case Report: Pigmented Epithelioid Melanocytoma (PEM)/Animal Type Melanoma (ATM): Quest for an Origin. Report of One Unusual Case Indicating Follicular Origin and Another Arising in an Intradermal Nevus

† Ashley Tarasen 1 , J. Andrew Carlson 2 , M. Kathryn Leonard 3 , Glenn Merlino 4 , David Kaetzel 3 and Andrzej T. Slominski

Received: 25 July 2017; Accepted: 10 August 2017; Published: 15 August 2017

Int. J. Mol. Sci. 2017, 18, 1769; doi:10.3390/ijms18081769


European Journal of Nuclear Medicine and Molecular Imaging

pp 1–7

18F-FDG-PET detects complete response to PD1-therapy in melanoma patients two weeks after therapy start

Ferdinand Seith, Andrea Forschner, Holger Schmidt, Christina Pfannenberg, Brigitte Gückel, Konstantin Nikolaou, Christian la Fougère, Claus Garbe, Nina Schwenzer

Short Communication

First Online: 22 August 2017

DOI: https://doi.org/10.1007/s00259-017-3813-2


New England Journal of Medicine

Correspondence

Melanoma Sentinel-Node Metastasis

N Engl J Med 2017; 377:891-892August 31, 2017DOI: 10.1056/NEJMc1708918


Int. J. Mol. Sci. 201718(9), 1875; doi:10.3390/ijms18091875

Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma 

Robert M. Hoffman 

Received: 5 August 2017 / Revised: 16 August 2017 / Accepted: 23 August 2017 / Published: 31 August 2017


ACS Nano

A Molecular-Targeted Immunotherapeutic Strategy for Melanoma via Dual-Targeting Nanoparticles Delivering Small Interfering RNA to Tumor-Associated Macrophages

Yuan QianSha QiaoYanfeng DaiGuoqiang XuBolei DaiLisen LuXiang YuQingming Luo, and Zhihong Zhang

ACS Nano, Just Accepted Manuscript

DOI: 10.1021/acsnano.7b05465

Publication Date (Web): August 31, 2017

Copyright © 2017 American Chemical Society


 

Menu